Recent data highlight BIMZELX's sustained effectiveness in relieving pain and resolving draining tunnels for patients with hidradenitis suppurativa over three years.

Avalo Therapeutics (Nasdaq: AVTX) announced completion of enrollment in its Phase 2 LOTUS trial of AVTX-009 for adults with hidradenitis suppurativa (HS).The trial exceeded its target of 222 patients with approximately 250 patients enrolled. LOTUS is a randomized, double-blind, placebo-controlled Phase 2 study (1:1:1) testing two AVTX-009 dose regimens versus placebo during a 16-week treatment phase. The primary endpoint is the proportion achieving HiSCR75 at Week 16. Secondary measures include HiSCR50/90, IHS4, draining fistula count, AN count, and PGA Skin Pain reductions. Topline data are expected in mid-2026. Trial identifiers: NCT06603077 and www.lotustrial.com.

Sinfully Yours - A Writer's Life One

No description available

The FDA approved expanded indications of Yuflyma and its unbranded version to treat hidradenitis suppurativa in adolescents aged 12 years and older and uveitis in children aged 2 years and older, according to a press release. Yuflyma (adalimumab-aaty, Celltrion, Inc.), approved May 21 as a fully interchangeable biosimilar to Humira across dosage forms and strengths, is indicated for multiple diseases including psoriatic arthritis, plaque psoriasis and rheumatoid arthritis, in addition to HS and uveitis in adults. “Adolescent HS and pediatric uveitis are chronic inflammatory conditions that can

The FDA approved expanded indications of Yuflyma and its unbranded version to treat hidradenitis suppurativa in adolescents aged 12 years and older and uveitis in children aged 2 years and older, according to a press release. Yuflyma (adalimumab-aaty, Celltrion, Inc.), approved May 21 as a fully interchangeable biosimilar to Humira across dosage forms and strengths, is indicated for multiple diseases including psoriatic arthritis, plaque psoriasis and rheumatoid arthritis, in addition to HS and uveitis in adults. “Adolescent HS and pediatric uveitis are chronic inflammatory conditions that can

Erica B's Excision Adventure 2025

Experts at the Skin of Color Update highlighted the potential benefits of GLP-1 RAs in managing obesity, as well as psoriasis and hidradenitis suppurativa symptom management.